Join us this March for the first ever CURE Patient-Focused Sessions, taking place at the Miami Breast Cancer Conference! 

×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Articles

Kristie L. Kahl
The Food and Drug Administration approved Imbruvica plus Gazyva for treatment-naïve patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
Brielle Benyon
One expert discusses how cancer and its treatments can have many lasting side effects on patients, from depression to peripheral neuropathy.
Katie Kosko
Nearly 90 percent of women experienced sexual dysfunction; however, providers were not openly communicating about this side effect, according to survey results.
Brielle Benyon
Certain factors – such as diastolic blood pressure and fasting insulin – were found to be associated with renal cell carcinoma.
Katie Kosko
African-Americans who received a racially matched liver had better survival outcomes compared with unmatched patients, according to a review of national data.
Brielle Benyon
Loneliness may play a key role in an individual’s social constraints following a cancer diagnosis and its treatment, which in turn, may worsen symptom burden, according to recent research.
Kristie L. Kahl
23andMe received Food and Drug Administration (FDA) clearance for a genetic health risk report on a hereditary colorectal cancer syndrome, according to the genetics company.
Katie Kosko
Penn Medicine launches program that allows people with brain tumors to access remote medical plans.
Kristie L. Kahl
A man with glioblastoma has received Gliovac (ERC1671) under legislation allowing for the terminally ill to try experimental drugs that have passed preliminary FDA testing.
Brielle Benyon
Here’s a resource for what FDA decisions mean – and how they affect patients.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other